These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15905490)

  • 1. Effect of CD3/CD28 bead-activated and expanded T cells on leukemic B cells in chronic lymphocytic leukemia.
    Patten P; Devereux S; Buggins A; Bonyhadi M; Frohlich M; Berenson RJ
    J Immunol; 2005 Jun; 174(11):6562-3; author reply 6563. PubMed ID: 15905490
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of CD3/CD28 bead-activated T cells on leukemic B cells in chronic lymphocytic leukemia.
    Prieto A; Sanchez M; Perucha E; Alvarez-Mon M
    J Immunol; 2005 Aug; 175(4):2042-3. PubMed ID: 16081767
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro engagement of CD3 and CD28 corrects T cell defects in chronic lymphocytic leukemia.
    Bonyhadi M; Frohlich M; Rasmussen A; Ferrand C; Grosmaire L; Robinet E; Leis J; Maziarz RT; Tiberghien P; Berenson RJ
    J Immunol; 2005 Feb; 174(4):2366-75. PubMed ID: 15699173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodies.
    Bohlen H; Hopff T; Manzke O; Engert A; Kube D; Wickramanayake PD; Diehl V; Tesch H
    Blood; 1993 Sep; 82(6):1803-12. PubMed ID: 7691238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The calcium-independent protein kinase C participates in an early process of CD3/CD28-mediated induction of thymocyte apoptosis.
    Asada A; Zhao Y; Komano H; Kuwata T; Mukai M; Fujita K; Tozawa Y; Iseki R; Tian H; Sato K; Motegi Y; Suzuki R; Yokoyama M; Iwata M
    Immunology; 2000 Nov; 101(3):309-15. PubMed ID: 11106933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies.
    Kalamasz D; Long SA; Taniguchi R; Buckner JH; Berenson RJ; Bonyhadi M
    J Immunother; 2004; 27(5):405-18. PubMed ID: 15314550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lymphocytic leukaemia cells become both activated and immunosuppressive following interaction with CD3 and CD28 stimulated PBMC.
    Hock BD; Macpherson SA; Fernyhough LJ; McKenzie JL
    Leuk Res; 2014 Oct; 38(10):1217-23. PubMed ID: 24976339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells.
    Renner C; Jung W; Sahin U; Denfeld R; Pohl C; Trümper L; Hartmann F; Diehl V; van Lier R; Pfreundschuh M
    Science; 1994 May; 264(5160):833-5. PubMed ID: 8171337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells.
    Carpenter PA; Pavlovic S; Tso JY; Press OW; Gooley T; Yu XZ; Anasetti C
    J Immunol; 2000 Dec; 165(11):6205-13. PubMed ID: 11086054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells.
    Blank C; Brown I; Marks R; Nishimura H; Honjo T; Gajewski TF
    J Immunol; 2003 Nov; 171(9):4574-81. PubMed ID: 14568931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FK506 enhances IL-13 production by T cells activated through CD3/CD28.
    Dumont FJ
    Int Arch Allergy Immunol; 1997 Nov; 114(3):300-1. PubMed ID: 9363914
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of cell expansion and surface molecule expression on anti-CD3/28 expanded CD4
    Thitilertdecha P; Poungpairoj P; Tantithavorn V; Ammaranond P; Onlamoon N
    Scand J Immunol; 2019 Nov; 90(5):e12808. PubMed ID: 31322752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD45RO+ T-cells immunoregulate spontaneous in vitro immunoglobulin production by normal and chronic lymphocytic leukaemia B-cells.
    Frolova EA; Scott SC; Jones RA
    Leuk Lymphoma; 1995 Jun; 18(1-2):103-11. PubMed ID: 8580811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells.
    Johnson-Léger C; Christensen J; Klaus GG
    Int Immunol; 1998 Aug; 10(8):1083-91. PubMed ID: 9723694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
    Broeren CP; Gray GS; Carreno BM; June CH
    J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new recombinant single chain trispecific antibody recruits T lymphocytes to kill CEA (carcinoma embryonic antigen) positive tumor cells in vitro efficiently.
    Wang XB; Zhao BF; Zhao Q; Piao JH; Liu J; Lin Q; Huang HL
    J Biochem; 2004 Apr; 135(4):555-65. PubMed ID: 15115782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation.
    Kusmartsev SA; Li Y; Chen SH
    J Immunol; 2000 Jul; 165(2):779-85. PubMed ID: 10878351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo.
    Yi LA; Hajialiasgar S; Chuang E
    Int Immunol; 2004 Apr; 16(4):539-47. PubMed ID: 15039384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3zeta-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells.
    Hombach A; Schlimper C; Sievers E; Frank S; Schild HH; Sauerbruch T; Schmidt-Wolf IG; Abken H
    Gut; 2006 Aug; 55(8):1156-64. PubMed ID: 16188919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2.
    Gargett T; Brown MP
    Cytotherapy; 2015 Apr; 17(4):487-95. PubMed ID: 25573334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.